Completing data — refresh the page later to see the latest
186611-04-1COc1ccccc1C=C1C(=O)Nc2ccccc21NEQZEVOPIKSAJP-UHFFFAOYSA-N186611-04-1Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesSU5214 is a potent VEGFR2 inhibitor extracted from patent US5834504A, SU5214, has IC50s of 14.8 μM (FLK-1) and 36.7 μM (EGFR), respectively[1].